Advertisement
News
Subscribe to MDT Magazine News

Pervasis broadens to cancer therapeutics, eyes new financings

January 20, 2011 12:40 pm | by Mass High Tech: The Journal of New England Technology | Comments

Pervasis Therapeutics Inc., which focuses on vascular surgical treatment, is expanding its coverage into oncology and considering additional financing from either a corporate partner or the venture capital community.

Awake despite anesthesia

January 20, 2011 12:34 pm | by EurekAlert | Comments

(Deutsches Aerzteblatt International) Unintended awareness during surgery is classified as an occasional complication of anesthesia (one to two in 1,000 patients) -- but being aware of things happening during the operation, and being able to recall them later, can leave a patient with...

TOPICS:

PSS buys Dispensing Solutions

January 20, 2011 11:45 am | by The Associated Press | Comments

Medical products distributor PSS World Medical Inc. said Thursday it paid an undisclosed amount for privately-held Dispensing Solutions Inc., which markets medical software for dispensing programs in the point of care, government, and contract packaging markets.Dispensing Solutions, which is...

Advertisement

Class I Medical Device Recall: Fresenius Medical Care North America, CombiSet True Flow Series Hemodialysis Blood Tubing Set with Priming Set and Transducer Protectors for Use...

January 20, 2011 11:38 am | by U.S. Food & Drug Administration | Comments

Reason for Recall: The hemodialysis blood tubing sets may develop kinking of the arterial line. Kinking can cause the destruction of red blood cells which may result in serious injury and/or death.

Ziopharm says lymphoma drug may get EU incentives

January 20, 2011 10:45 am | by The Associated Press | Comments

Drugmaker Ziopharm Oncology Inc. said Thursday its lymphoma drug candidate Zinapar was recommended for orphan drug incentives in the European Union.Ziopharm said a committee in the European Medicines Agency recommended that Zinapar be awarded orphan drug status, which is granted to drugs that...

TSX-listed corporate dividends and distributions declared Jan. 20, 2010

January 20, 2011 10:45 am | by The Associated Press | Comments

Dividends or distributions were declared or updated on the followed listed issues on the Toronto Stock Exchange on January 20, 2011.Northland Power Inc. (TSX:NPI): $0.09. Payable Jan 14. Record Dec 31.Enervest Diversified Income Trust Units (TSX:EIT.UN): $0.1. Payable Feb 15. Record Jan...

Dino-era sex riddle solved by new fossil find

January 20, 2011 10:39 am | by EurekAlert | Comments

(University of Leicester) Killed and preserved with her egg, a fossil of a flying reptile shows for the first time how hips and crests can be used to sex pterodactyls.

TOPICS:

A novel function of anti-diuretic hormone vasopressin in the brain

January 20, 2011 10:38 am | by EurekAlert | Comments

(National Institute for Physiological Sciences) The anti-diuretic hormone "vasopressin" is released from the brain, and known to work in the kidney, suppressing the diuresis. Here, the Japanese research team led by professor Yasunobu Okada, Director-General of NIPS, Japan,...

TOPICS:
Advertisement

Text of Delaware State of the State

January 20, 2011 9:45 am | by The Associated Press | Comments

Here is the text of Delaware Gov. Jack Markell's State of the State address:Lt. Governor Denn, President Pro Tem DeLuca, Speaker Gilligan, members of the 146th General Assembly, statewide elected officials, members of the Judiciary, members of the Cabinet, State employees, Carla, family and the...

Biolase surges on strong 2011 revenue outlook

January 20, 2011 9:45 am | by The Associated Press | Comments

Shares of Biolase Technology Inc. nearly doubled in value Thursday after the dental laser company forecast much higher revenue in 2011 than Wall Street expected.Biolase expects $55 million to $60 million in revenue this year. Analysts forecast $40.4 million on average, according to estimates...

Vertex hepatitis C drug wins FDA priority review

January 20, 2011 9:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Vertex Pharmaceuticals Inc. has won priority review from the U.S. Food and Drug Administration for its hepatitis C virus treatment, telaprevir. The drug is expected to receive an approval decision on May 23.

Anika Therapeutics appoints Thompson to board

January 20, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Anika Therapeutics Inc., a Bedford-based tissue products company, has named to its board of directors Jeffrey Thompson, chairman and CEO of Advanced Bio-Technologies Inc., a scar treatment developer, in Georgia.

Stryker Corporation Named One of FORTUNE Magazine's '100 Best Companies to Work For'

January 20, 2011 8:46 am | by Bio-Medicine.Org | Comments

KALAMAZOO, Mich.. Jan. 20, 2011 /- Stryker Corporation (NYSE: SYK ) announced today that it has been named one of the "100 Best Companies to Work For" by FORTUNE in the magazine's 14th annual survey of top-rated workplaces in the United States.  This is Stryker's first time to be...

TOPICS:

W. L. Gore & Associates Continues Its Tradition as One of Nation's Best Workplaces

January 20, 2011 8:46 am | by Bio-Medicine.Org | Comments

NEWARK, Del., Jan. 20, 2011  /- With its unique, non-hierarchical, team-based culture, global manufacturing company W. L. Gore & Associates has once again earned a spot on FORTUNE magazine's annual list of the 100 Best Companies to Work for in America. The company is ranked No....

TOPICS:

TheCarrot.com Launches Quit Smoking Program

January 20, 2011 8:46 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, Jan. 20, 2011 /- TheCarrot.com , a leading provider of online and mobile consumer health engagement programs, announced the immediate availability of its new Quit Smoking Program. Drawing on the expertise of the University of California at San Francisco's Smoking Cessation...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading